EUVIMEDEUVIMED entdecken
Crossref

SGLT2 Inhibitors in Vascular Protection: Modulating Tonic VEGF Signaling and Preventing Rarefaction

Joao Carlos Ribeiro-Silva

Current Opinion in Physiology · 2026-11 · 101010

DOI: 10.1016/j.cophys.2026.101010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Opinion in Physiology, 2026-11. Verfasst von Joao Carlos Ribeiro-Silva. Die Arbeit nennt 74 Literaturangaben. Gefördert von: American Heart Association Inc.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • American Heart Association Inc

Zitieren

APA

Ribeiro-Silva, J. C. (2026). SGLT2 Inhibitors in Vascular Protection: Modulating Tonic VEGF Signaling and Preventing Rarefaction. Current Opinion in Physiology, 101010. https://doi.org/10.1016/j.cophys.2026.101010

Vancouver

Ribeiro-Silva JC. SGLT2 Inhibitors in Vascular Protection: Modulating Tonic VEGF Signaling and Preventing Rarefaction. Current Opinion in Physiology. 2026:101010. doi:10.1016/j.cophys.2026.101010

BibTeX
@article{RibeiroSilva2026,
  author = {Ribeiro-Silva, Joao Carlos},
  title = {SGLT2 Inhibitors in Vascular Protection: Modulating Tonic VEGF Signaling and Preventing Rarefaction},
  journal = {Current Opinion in Physiology},
  year = {2026},
  pages = {101010},
  doi = {10.1016/j.cophys.2026.101010}
}
Kostenlos starten →